US Stocks
/
Bicara Therapeutics Inc. Share Price
Bicara Therapeutics Inc. Share Price

Bicara Therapeutics Inc. Share Price

NASDAQ: BCAX | Mega Cap
$22.64
+$0.06 (0.24%) Last updated on 19 Sep, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Bicara Therapeutics Inc. Stock Performance

Open
$22.82
Prev. Close
$22.58
Circuit Range
N/A
Day Range
$22.33 - $22.86
Year Range
$10.33 - $30.93
Volume
46,231
Average Traded
$22.64

Bicara Therapeutics Inc. Share Price Today

As of 19 September 2026, Bicara Therapeutics Inc.'s share price is $22.64. The stock opened at $22.82, compared to its previous close of $22.58. During today's trading session, Bicara Therapeutics Inc.'s share price traded between $22.33 and $22.86, with an average price of $22.59. Over the past 52 weeks, the stock has recorded a high of $30.93 and a low of $10.33. In terms of performance, Bicara Therapeutics Inc.'s share price has risen by 13.89% over the last six months and is up 43.30% on a year-on-year basis.

Bicara Therapeutics Inc. Share Price Chart

$22.33$22.86
L
Show Current Price
H

Bicara Therapeutics Inc. Stock Fundamentals & Key Indicators

Market Cap
$1.24T
PE Ratio (TTM)
-8.98
Dividend Yield
N/A
EPS (TTM)
$-2.52
Revenue (TTM)
N/A
Return On Equity (TTM)
-34.36%
Profit Margin
N/A
Debt to Equity
0.07
Quarterly Earnings Growth YoY
-107.83%

Bicara Therapeutics Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2024Mar 2025Jun 2025Sep 2025
RevenueN/AN/AN/AN/A
Net Profit-$17.48M-$36.85M-$27.39M-$36.33M
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-110.78%25.67%-32.65%

Bicara Therapeutics Inc. Annual Profit & Loss

All figures in USD

Particulars20242025
RevenueN/AN/A
Net Profit-$68.00M-$137.95M
Net Profit MarginN/AN/A
Income ChangeN/A-102.88%

About Bicara Therapeutics Inc.

Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines a clinically validated epidermal growth factor receptor directed monoclonal antibody with a domain that binds to human transforming growth factor beta for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts.

Bicara Therapeutics Inc. Historical Returns

MonthOpenCloseChange %
Sep 2026
$22.73
$22.64
-8.76%
Aug 2026
$26.24
$24.82
-8.41%
Jul 2026
$29.55
$27.10
-8.69%
Jun 2026
$21.02
$29.68
+36.52%
May 2026
$21.57
$21.74
+0.51%
Apr 2026
$20.14
$21.63
+8.83%
Mar 2026
$16.43
$19.88
+18.30%
Feb 2026
$17.00
$16.80
+0.00%
Jan 2026
$16.50
$16.80
-0.12%
Dec 2025
$17.82
$16.82
-9.28%
Nov 2025
$15.87
$18.54
+14.13%
Oct 2025
$16.27
$16.25
+2.85%

BCAX Share Price FAQs

What is Bicara Therapeutics Inc. share price today?

chevron-up
Bicara Therapeutics Inc. share price today is $22.64 as on September 19, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Bicara Therapeutics Inc. stock?

chevron-up
The 52 week high of Bicara Therapeutics Inc. stock is $30.93, while the 52 week low is $10.33 as of 19 Sep '26.

What is BCAX's market capitalisation today?

chevron-up
BCAX market capitalisation is $1.24T as of September 19, 2026, at 10:52 pm IST.

What is BCAX's net income for the last quarter?

chevron-up
BCAX's net income for the last quarter is -0.04B USD.

What is the 5 year returns of BCAX?

chevron-up
The 5 year returns of BCAX is -10.85% as on 19 Sep '26.

What is the high & low stock price of BCAX today?

chevron-up
BCAX stock price hit a high of $22.86 and low of $22.33 as of 19 Sep '26.

Can I buy BCAX shares in India?

chevron-up
Yes. You can buy BCAX in India by opening an international trading account.